Azithromycin Powder, For Suspension
Product Images NDC 0093-2026

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Azithromycin (NDC 0093-2026). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Teva Pharmaceuticals Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image 1

Chemical structure of azithromycin, a macrolide antibiotic molecule with multiple rings and attached methyl and hydroxyl groups, depicted with standard chemical bonding notation.*

FDA Label Image

Image 2

Packaging label for Azithromycin Oral Suspension USP 100 mg per 5 mL (300 mg per 15 mL when mixed), a powder for oral suspension. The label is cherry flavored and displays directions for use, storage instructions, and manufacturer information. It is labeled for prescription use and manufactured by Teva Pharmaceuticals USA, Inc.*

FDA Label Image

Image 3

Carton packaging label for Azithromycin oral suspension USP, 200 mg per 5 mL strength (600 mg per 15 mL when mixed), powdered for oral suspension. The product is cherry flavored and intended for oral use only. Labeler is Teva Pharmaceuticals USA, Inc. The label includes NDC 0093-2026-23, storage instructions, dosing directions, barcodes, and manufacturer information indicating production in Croatia.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.